News • Oncology
Potential new target for cancer treatment
Inhibition of the enzyme RIOK1 could stop the growth of tumors and the development of metastases
Tumour
News • Oncology
Radiotherapy could extend lives of pancreatic cancer patients
Patients with early stage pancreatic cancer could be given longer to live if they receive radiotherapy at a high enough dose, according to research presented at the ESTRO 36 conference.
News • Study
Single high-dose radiation especially effective against prostate tumours
Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumour results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses.
News • Oncology
A clue to where cancer metastases are born
Even in remission, cancer looms. Former cancer patients and their doctors are always on alert for metastatic tumors. Now scientists at The Scripps Research Institute (TSRI) have discovered why some cancers may reoccur after years in remission.
News • Study
Link between blood sugar and brain cancer found
New research further illuminates the surprising relationship between blood sugar and brain tumors and could begin to shed light on how certain cancers develop. While many cancers are more common among those with diabetes, cancerous brain tumors called gliomas are less common among those with elevated blood sugar and diabetes, a study from The Ohio State University has found. The discovery builds…
Article • Hirnübungen I
Neuro MR: What‘s new in brain tumors?
From the extremely new, but not very available, to the somewhat new, very available and highly useful, Walter Kucharczyk will cover the potentials and practicalities in advanced brain tumor imaging.
News • Oncology
Treating cancer with drugs for diabetes and hypertension
A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells. The team of researchers led by Prof. Michael Hall at the Biozentrum of the University of Basel has also reported that specific cancer cells respond to this combination of drugs.
News • Single-Cell Isolation Technology
Predicting a response to treatment in patients with lung cancer
Menarini-Silicon Biosystems announced the company’s DEPArray single-cell isolation technology played a key role in a study conducted by researchers from The University of Manchester to develop a model for predicting whether small-cell lung cancer patients will be sensitive or resistant to initial chemotherapy treatment.
Article • Neurology
The 3-D printed brain tumour
3-D printed tumour-like constructs will be used by a research team at Scotland’s Heriot-Watt University in Edinburgh, to raise research to a new level and successfully lead to new treatment options.
Article • Brain functions transfer
Pioneering cancer surgery
Brain cancer treatment is taking a major step ahead as Spanish surgeons pioneer a new technique that spares language and motion functions. This splendid development might even one day result in epilepsy surgery.
Article • Detecting bladder tumours
Photodynamic diagnosis locates the smallest tumours
Bladder cancer (BC) is the most common malignancy involving the urinary system and the ninth most common malignancy worldwide.
Article • Multi-parametric imaging
50 shades of grey in hybrid imaging
Fusion imaging will create a multi-modality monster for radiology groups that already struggle to deal with data from dual-modality hybrid systems. It’s like acquiring a Porsche but only able to use 1st gear.
Article • CEUS
Only convincing with contrast
Contrast enhanced ultrasound is part of clinical routine and makes a substantial contribution towards increasing the significance of tissue and organ diagnosis with ultrasound for difficult cases.
News • Oncology
Loophole for cancer cells
Many cancers only become a mortal danger if they form metastases elsewhere in the body. Such secondary tumours are formed when individual cells break away from the main tumour and travel through the bloodstream to distant areas of the body. To do so, they have to pass through the walls of small blood vessels. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and…
News • Low Oxygen, High Risk
How tumors adapt to become more aggressive
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions. Hypoxia, or a lack of oxygen, is one example of a phenomenon that should weaken the tumor, but instead, the malignant cells are able to compensate and drive more aggressive disease behavior.
News • Counterproductive
Breast tumors evolve in response to hormone therapy
Many breast tumors grow in response to female hormones, especially estrogen. Drugs that reduce estrogen levels in the body often are effective in reducing tumor size and preventing recurrence of the cancer. But some tumors become resistant to these therapies and continue to grow and spread.
News • Research
New Biomarker for cancer immunotherapy?
The Ligand PD-L1 is one of the most important targets for cancer immunotherapy with checkpoint inhibitors. But not all tumors have sufficient quantities of PD-L1 ligands on their surface. Scientists from the German Cancer Consortium (DKTK) have now shown that different types of cancer possess different quantities of PD-L1-Gen copies. Genetic analysis of the PD-L1 gene may in the future help to…
News • Tumor removal
3D printed kidney helps save woman's organ
Doctors and scientists at Intermountain Medical Center in Salt Lake City printed and used a 3D kidney to help save a patient's organ during a complicated tumor-removal procedural. The 3D-printed model allowed doctors to study the patient's kidney in 3D to determine how to best remove the tumor as it was located in a precarious location adjacent to vital arteries and veins. Thanks to the model of…
News • From nanotechnology
A better prognostic tool for brain cancer
A new nano-fabricated platform for observing brain cancer cells provides a much more detailed look at how the cells migrate and a more accurate post-surgery prognosis for brain cancer (glioblastoma) patients.
News • Individual treatment
Molecular sub-groups in early stages of bladder cancer
Bladder cancer is a frequent disease affecting approximately 1,900 persons in Denmark annually. A high number of these patients only have superficial tumours in the bladder when the disease is diagnosed. For many years, this patient group will be examined frequently and during this time many get new tumours; some cases develop aggressively making it necessary to remove the bladder or receive…
News • Research
New drivers of rare cancer type identified
Cancer researchers from the Würzburg University, in cooperation with the international Cancer Genome Atlas Research Network, have identified new genetic drivers of adrenal cancer. Würzburg was the center of coordination of the European scientists.
News • Active substance
Promising treatment prospects for invasive breast cancer
Scientists from the University of Zurich have been able to understand for the first time why many cancer cells adapt relatively quickly to the treatment with therapeutic antibodies in invasive forms of breast cancer. Instead of dying off, they are merely rendered inactive. The researchers have now developed an active substance that kills the cancer cells very effectively without harming healthy…
News • Oncology
How printing a 3-D skull helped save a real one
What started as a stuffy-nose and mild cold symptoms for 15-year-old Parker Turchan led to a far more serious diagnosis: a rare type of tumor in his nose and sinuses that extended through his skull near his brain. “He had always been a healthy kid, so we never imagined he had a tumor,” said Parker’s father, Karl. “We didn’t even know you could get a tumor in the back of your nose.”
Article • Ovarian cancer
The story of the silent killer
Andrea G. Rockall, Consultant Radiologist at the Royal Marsden Hospital and Visiting Professor of Radiology at Imperial College in London, delivered the prestigious Wilhelm Conrad Röntgen Honorary Lecture at ECR 2016 on ‘Imaging the invisible killer: towards personalisation of ovarian cancer care’.
News • Oncology
Pancreatic cancer: Enzyme renders tumors resistant
Scientists at the German Cancer Research Center (DKFZ) and the Stem Cell Institute HI-STEM in Heidelberg have discovered the reason why some pancreatic tumors are so resistant to treatment. They have found that these tumor cells produce larger quantities of an enzyme that usually occurs in the liver and degrades many drugs. If this enzyme is blocked, the cancer cells become sensitive towards…